Literature DB >> 25277845

Pre-deployment differences in glucocorticoid sensitivity of leukocytes in soldiers developing symptoms of PTSD, depression or fatigue persist after return from military deployment.

Mirjam van Zuiden1, Annemieke Kavelaars2, Eric Vermetten3, Miranda Olff4, Elbert Geuze5, Cobi Heijnen6.   

Abstract

Deployed soldiers are at risk of developing stress-related conditions, including posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and severe fatigue. We previously observed condition- and cell-specific differences in sensitivity of immune cells for regulation by glucocorticoids (GCs) pre-deployment between male soldiers with and without subsequent development of high levels of these stress-related symptoms. Here we investigated whether these pre-deployment dysregulations in GC-sensitivity of immune cells persisted after return from military deployment. In a prospective, longitudinal study including 721 male and female soldiers, the in vitro GC-sensitivity of monocytes and T-cells was assessed prior to deployment and one and six months post-deployment. Differences in the longitudinal course of sensitivity for regulation by dexamethasone (DEX) of LPS-stimulated TNF-α production and PHA-stimulated T-cell proliferation between soldiers with and without subsequent symptom development were investigated using linear mixed models. Within the whole group, DEX-sensitivity of monocytes was significantly decreased at six months post-deployment compared to the assessments pre-deployment and one month post-deployment. The DEX-sensitivity of T-cells did not significantly change over time. Participants developing high levels of PTSD symptoms showed high DEX-sensitivity of T-cells, while participants developing high levels of depressive symptoms showed low DEX-sensitivity of T-cells before deployment that persisted at the two time points after return. In addition, participants developing severe fatigue had low DEX-sensitivity of monocytes at all assessments. Our finding that the previously observed pre-deployment group differences in peripheral GC-sensitivity persisted until at least six months after return indicates that in vitro GC-sensitivity of T-cells and monocytes may represent a persistent biological vulnerability factor for development of stress-related conditions PTSD, depression and fatigue.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Combat; Depression; Fatigue; Glucocorticoid receptor; PTSD; Stress

Mesh:

Substances:

Year:  2014        PMID: 25277845     DOI: 10.1016/j.psyneuen.2014.09.014

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  11 in total

Review 1.  The Need to Take a Staging Approach to the Biological Mechanisms of PTSD and its Treatment.

Authors:  Alexander Cowell McFarlane; Eleanor Lawrence-Wood; Miranda Van Hooff; Gin S Malhi; Rachel Yehuda
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

2.  Evidence for Immune Activation and Resistance to Glucocorticoids Following Childhood Maltreatment in Adolescents Without Psychopathology.

Authors:  Carine Hartmann do Prado; Rodrigo Grassi-Oliveira; Ledo Daruy-Filho; Andréa Wieck; Moisés Evandro Bauer
Journal:  Neuropsychopharmacology       Date:  2017-06-30       Impact factor: 7.853

Review 3.  Co-morbidity of PTSD and immune system dysfunction: opportunities for treatment.

Authors:  Gretchen N Neigh; Fariya F Ali
Journal:  Curr Opin Pharmacol       Date:  2016-07-29       Impact factor: 5.547

4.  Glucocorticoid mediated regulation of inflammation in human monocytes is associated with depressive mood and obesity.

Authors:  Tiefu Cheng; Stoyan Dimitrov; Christopher Pruitt; Suzi Hong
Journal:  Psychoneuroendocrinology       Date:  2016-01-12       Impact factor: 4.905

Review 5.  Reexamination of diathesis stress and neurotoxic stress theories: A qualitative review of pre-trauma neurobiology in relation to posttraumatic stress symptoms.

Authors:  Michael S Scheeringa
Journal:  Int J Methods Psychiatr Res       Date:  2020-11-21       Impact factor: 4.035

Review 6.  Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics.

Authors:  Tamara E Lacourt; Cobi J Heijnen
Journal:  Curr Breast Cancer Rep       Date:  2017-04-22

7.  Discovery and replication of a peripheral tissue DNA methylation biosignature to augment a suicide prediction model.

Authors:  Makena L Clive; Marco P Boks; Christiaan H Vinkers; Lauren M Osborne; Jennifer L Payne; Kerry J Ressler; Alicia K Smith; Holly C Wilcox; Zachary Kaminsky
Journal:  Clin Epigenetics       Date:  2016-11-03       Impact factor: 6.551

8.  Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders.

Authors:  A R Tyrka; S H Parade; E S Welch; K K Ridout; L H Price; C Marsit; N S Philip; L L Carpenter
Journal:  Transl Psychiatry       Date:  2016-07-05       Impact factor: 6.222

Review 9.  Vulnerability or Sensitivity to the Environment? Methodological Issues, Trends, and Recommendations in Gene-Environment Interactions Research in Human Behavior.

Authors:  Caroline Leighton; Alberto Botto; Jaime R Silva; Juan Pablo Jiménez; Patrick Luyten
Journal:  Front Psychiatry       Date:  2017-06-15       Impact factor: 4.157

Review 10.  Literature review and methodological considerations for understanding circulating risk biomarkers following trauma exposure.

Authors:  Sarah D Linnstaedt; Anthony S Zannas; Samuel A McLean; Karestan C Koenen; Kerry J Ressler
Journal:  Mol Psychiatry       Date:  2019-12-20       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.